Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
株式のランク #14752
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
株価
$2.35
時価総額
$394.12M
変化(1日)
-1.07%
変化(1年)
-64.75%
TW
取引 Lumosa Therapeutics Co., Ltd. (6535)

カテゴリー

Lumosa Therapeutics Co., Ltd.(6535)の株価履歴
終値の最高値: $2.35 (2026-09-01)

終値の最安値: $1.29 (2015-07-01)
Lumosa Therapeutics Co., Ltd. の株価履歴(2015 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -11.24%
2025 -7.99%
2024 206.71%
2023 67.55%
2022 -8.12%
2021 11.91%
2020 4.84%
2019 18.82%
2018 1.29%
2017 -28.93%
2016 -36.03%
2015 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$550.99 40.91%
US
$1.04K 45.51%
NL
$121.37 -11.93%
AU
$145.15 502.53%
US
$747.56 4.77%
CH